Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-27

Clinical Trial Update: Venoactive Drug Treatment of Pelvic Venous Disorders [Phase 3]

View source ↗

Summary

This document reports a Phase 3 clinical trial evaluating a venoactive drug for pelvic venous disorders that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venoactive Drug

Snippet

Sponsor: Pirogov Russian National Research Medical University | Conditions: Pelvic Venous Disorders | Phase 3 | Status: RECRUITING